OCULIS-1006x250.png
Oculis appoints Dr. Bastian Dehmel as Chief Development Officer
08. Februar 2022 07:43 ET | Oculis
Oculis appoints Dr. Bastian Dehmel as Chief Development Officer Former Amgen Global Development Leader/OxThera CMO joins Oculis as Chief Development Officer to lead development planning and drive...